Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

Dr. Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

The Second Xiangya Hospital of Central South University | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Hui Li began her academic journey with a strong interest in internal medicine, which laid the foundation for her later specialization. Her doctoral studies at Central South University equipped her with in-depth knowledge of the mechanisms of disease progression and clinical applications. These formative years shaped her scientific curiosity and commitment to advancing research that bridges clinical practice and basic science.

Professional Endeavors

Prof. Li currently serves as the Associate Director of the Institute of Anesthesiology at Central South University, where she has taken on leadership responsibilities in guiding both clinical and academic teams. She has successfully secured competitive national research funding and has consistently contributed to the advancement of anesthesiology and perioperative medicine. Her role also extends to mentoring young researchers and postgraduate students, thereby strengthening the academic environment of her institution.

Contributions And Research Focus

Her primary research focus revolves around perioperative organ protection and neuro immune regulation. Prof. Li has explored the underlying biological mechanisms that influence patient outcomes during and after surgery, with an emphasis on protecting vital organs from damage. Her work highlights the intricate interaction between the nervous and immune systems in the perioperative setting, contributing valuable insights to both anesthesiology and internal medicine.

Impact And Influence

Prof. Li has published extensively in reputable international journals, including contributions to highly respected platforms such as Nature Communications, Cell Death and Disease, and Cardiovascular Diabetology. Through these publications, her findings have gained global recognition and have provided new directions for clinical research. Her influence extends beyond her own institution, as her research is frequently cited and built upon by other scholars in the field.

Academic Cites

The scholarly impact of Prof. Li is evident in the citations her work has received in the global academic community. Her contributions are referenced in multiple studies across anesthesiology, immunology, and cardiovascular research. This academic visibility underscores the relevance and applicability of her research in interdisciplinary domains.

Legacy And Future Contributions

Prof. Li’s academic legacy lies in her ability to connect molecular insights with practical clinical applications. Her work on organ protection and neuro immune pathways not only advances the field of anesthesiology but also has broader implications for perioperative care and long term patient recovery. Looking ahead, her continued leadership and innovative studies are expected to shape future standards in patient safety, anesthesia practices, and translational medicine.

Conclusion

Prof. Hui Li stands as a distinguished academic whose career reflects dedication to clinical innovation and scientific excellence. With her leadership in anesthesiology, her significant body of research, and her growing academic influence, she continues to contribute meaningfully to both scientific advancement and medical practice. Her trajectory promises further breakthroughs that will enhance patient outcomes and inspire future generations of researchers.

Notable Publications

"Random forest algorithm for predicting postoperative hypotension in oral cancer resection and free flap reconstruction surgery"

Authors: Shuiting Zhang, Yanling Zhang, Xinyu Ouyang, Hui Li , Ruping Dai
Journal: Scientific Reports
Year: 2025

"Monocytes perturbation implicated in the association of stress hyperglycemia with postoperative poor prognosis in non-diabetic patients with Stanford type-A acute aortic dissection"

Authors: Shuai Zhao, Di Fu, Wei Luo, Wei-Yun Shen, Xue-Mei Miao, Jia-Ying Li, Jing-Ying Yu, Qian Zhao, Hui Li, Ru-Ping Dai
Journal: Cardiovascular Diabetology
Year: 2024

Mengchao Wei | Venous thromboembolism | Best Researcher Award

Dr. Mengchao Wei | Venous thromboembolism | Best Researcher Award

Dr. Mengchao Wei, Peking Union Medical College Hospital, China

Dr. Mengchao Wei is a physician at Peking Union Medical College Hospital, China, specializing in Urology. He graduated with a Doctor’s degree from Sun Yat-sen University in 2019. Since joining PUMCH in 2021, Dr. Wei has focused on optimizing perioperative management for urologic surgeries. He developed a predictive model for venous thromboembolism risk post-surgery, now integrated into clinical practice. Dr. Wei has published 10 journal articles in SCI and Scopus indexed journals. His research aims to improve patient safety and surgical outcomes, making significant contributions to the field of urologic surgery.

Author Profile

Orcid Profile

📚Early Academic Pursuits: 

Dr. Mengchao Wei graduated with a Doctor’s degree from Sun Yat-sen University in 2019. His academic journey laid the foundation for his current work, particularly in the field of Urology, where he became deeply involved in understanding the nuances of perioperative management in urologic surgeries. His comprehensive training and early research set him on a path to clinical excellence and innovation.

⚕️Professional Endeavors and Contributions: 

Since 2021, Dr. Wei has been practicing as a Physician at Peking Union Medical College Hospital, where his focus lies in the optimization of perioperative management in urologic surgeries. His clinical work has had a direct impact on improving patient care and the efficiency of surgical outcomes. Dr. Wei’s contributions include the development of a predictive model for venous thromboembolism risk following urologic surgeries, which has been implemented in real-world clinical practice to enhance patient safety.

🔬Research Focus and Innovations on Venous thromboembolism:

Dr. Wei’s research centers on perioperative management within urology, particularly concerning venous thromboembolism (VTE) risk. His predictive model for VTE risk, now utilized in clinical settings, showcases his ability to translate research into tangible, life-saving outcomes. While his citation index stands at 10, his work continues to gain attention in the medical community. He has published 10 journals in esteemed databases such as SCI and Scopus, reinforcing his status as a respected figure in urologic research.

🌍Impact and Influence: 

Dr. Wei’s contributions have not only benefited his hospital but also shaped the way urologic surgeries are managed perioperatively. By providing a tool that enhances clinical decision-making, he directly improves surgical outcomes, patient safety, and overall healthcare efficiency. His work has influenced peers, setting a new standard in the field of urology.

📑Academic Citations:

Dr. Wei has an impressive citation index of 10, a reflection of the growing recognition of his work and the clinical value it brings. His research continues to receive acknowledgment in relevant medical journals, contributing to the advancement of perioperative care in urology.

🚀Legacy and Future Contributions: 

Dr. Wei’s research and innovations indicate a promising future in the field of urology. He is committed to enhancing perioperative management for urologic surgeries and advancing clinical practices. Moving forward, his aim is to refine predictive models and further contribute to patient safety and surgical excellence.

🌟Conclusion:

Dr. Mengchao Wei’s work at Peking Union Medical College Hospital has made a significant impact on perioperative management in urologic surgeries. His predictive model for venous thromboembolism risk has been successfully integrated into clinical practice, improving patient outcomes and safety. With 10 journal publications in SCI and Scopus indexed journals, Dr. Wei is recognized as a dedicated and innovative physician. His contributions are shaping the future of urologic surgery. As he continues to push the boundaries of medical research, his work promises to enhance the quality of care and patient safety worldwide.

Top Notable Publications 

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries

Authors: Mengchao Wei

Journal: Scientific Reports

Year: 2025

The role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinoma

Authors: Mengchao Wei

Journal: BMC Urology

Year: 2024

Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial

Authors: Mengchao Wei

Journal: World Journal of Urology

Year: 2024

Surgery or external beam radiation for solitary small hepatocellular carcinoma

Authors: Mengchao Wei

Journal: Journal of Cancer Research and Therapeutics

Year: 2023

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy

Authors: Mengchao Wei

Journal: Frontiers in Oncology

Year: 2022

Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2022

The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer

Authors: Mengchao Wei

Journal: International Journal of Radiation Oncology, Biology, Physics

Year: 2022

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2020

Radiofrequency ablation plus nucleotide analogues for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis

Authors: Mengchao Wei

Journal: American Journal of Translational Research

Year: 2018

Sorafenib versus Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Authors: Mengchao Wei

Journal: BMC Cancer

Year: 2018